Non-Communicable Diseases

Screen Shot 2020-02-03 at 9.05.02 PM
Play Video

Featured Story

Fighting NCDs

See how our cervical cancer prevention program in Trinidad & Tobago, supported through PSI’s Maverick Collective, is partnering with the Ministry of Health to pilot new technologies for improved cervical cancer screening and bolstering national efforts to raise awareness of cervical cancer and the need for HPV vaccine and regular screening.


Non-communicable diseases (NCDs) were once considered to be challenges for affluent countries alone. But now, cardiovascular diseases, cancer, diabetes and other NCDs have emerged as the leading cause of death and disability worldwide, responsible for 41 million or 71% of all deaths annually.

The global burden of NCDs is increasing, and they disproportionately affect the developing world. In fact, more than 85% of premature deaths resulting from NCDs–those that occur from 30-69 years of age—occur in low- and middle-income countries and pose serious consequences for both individuals, families and communities. Since NCDs often strike during a person’s most productive years, they impede the broader economic development of these countries as well.

Tobacco use, physical inactivity, the harmful use of alcohol and unhealthy diets all increase the risk of death due to common NCDs. PSI focuses on moving our clients and providers across the spectrum of care for NCDs, from raising awareness to detection and management of diseases, with a focus on:

  • Cervical cancer prevention through HPV vaccine promotion, early detection and treatment of cervical pre-cancers and referral for follow-on care
  • Cardiovascular disease prevention through awareness, early detection and management of hypertension and type 2 diabetes

How we

Asset 17


Asset 26

Market Development



Asset 9


The Three Pillars of our Work in
Non-Communicable Diseases


We work through cross-sectoral partnerships to address market gaps.

Learn More

We support global, cross-sectoral NCD initiatives to achieve global goals.

Learn More

Incorporating care for NCDs into the primary healthcare agenda

Learn More


In 2019, PSI's NCD programming reached over 880,000 users, including:



women across PSI's global network were screened for cervical cancer


people were screened for hypertension


people were screened for Type 2 Diabetes

Our NCD Solutions

In countries where cervical cancer rates are highest, informed access to contraception and HIV testing also remains a critical need. PSI systematically designs, tests and refines integrated sexual and reproductive health service delivery models to meet consumer needs, while improving health outcomes.

PSI liaises with manufacturers to identify new technologies for cervical cancer screening and pre-cancer treatment. We pilot technologies to understand their potential for both consumers and providers, to the impact for scale in low- and middle-income countries.

It is often challenging for consumers to maintain long-term hypertension treatment regimens. PSI explores ways to facilitate greater market presence and update of hypertension treatment protocols to include FDCs for the improvement of medication adherence.

Development assistance for health is shifting away from traditional, institutional donors to nontraditional sources. PSI has been at the forefront of cross-sector partnerships in global health; PSI’s NCD projects create successful partnerships with both corporate and philanthropic partners. PSI continues to innovate its partnership models to drive efficiency and impact.

Featured Projects

Self-Care Trailblazers Group

Donor: Children’s Investment Fund Foundation; The William and Flora Hewlett Foundation

+ Read More

Non-Communicable Disease Program for Trinidad and Tobago

Donor: JB Fernandez Memorial Trust

+ Read More

PEER: Evaluating innovative technologies and approaches to addressing cervical cancer in the Republic of Mozambique

Donor: USAID and the National Academies of Science

Project Lead: MD Anderson Cancer Center

+ Read More

Increasing Public Sector Capacity for Diabetes Management in Laos

Donor: World Diabetes Foundation

+ Read More

Integrating diabetes and HIV services in Eswatini

Donor: World Diabetes Foundation

+ Read More

Intergenerational Approaches to Prevent and Treat Cervical Cancer in the Caribbean

Donor: Julia Lourie, Maverick Collective Member

+ Read More


Cat Normile

Manager, Strategic Partnerships PSI
Jen Pope

Jennifer Pope

Vice President, Sexual and Reproductive Health PSI Global
Dr. Eva Lathrop

Dr. Eva Lathrop

Global Medical Director PSI Global


Discover what's happening at PSI

Webinar: Addressing Cervical Cancer and SRH Needs During the COVID-19 Pandemic

This week, TogetHER for Health hosted PSI’s Dr. Milly Nanyombi Kaggwa, alongside CEO Mary Eiken and Director of Global Outreach and Engagement Dicey Jackson Scroggins of the International

+ Read More

Cervical Cancer is Preventable – Even Amidst COVID-19

Half of women with cervical cancer will die — all from a disease that is completely preventable with the right resources and tools. It doesn’t

+ Read More

International Women’s Day: I am Generation Equality

Two generations of Maverick Collective Members, Julia Lourie and Kathy Vizas, co-founder of TogetHER for Health, advocated and invested in PSI’s cervical cancer programming across

+ Read More

Advancing Primary Health Care in Myanmar

Non-communicable diseases (NCDs) are the leading cause of global mortality. Hypertension — persistently elevated blood pressure — is the single most important risk factor for

+ Read More

From Half a Million Deaths to Zero: Cervical Cancer Screening in Mozambique

Half a million women are diagnosed with cervical cancer every year—and 50% of these cases are fatal. Most cases of cervical cancer now occur in

+ Read More

Put Power Where It Belongs

By Karl Hofmann, PSI President and CEO   We live in a fascinating time. For all of us working in global health, we can thank President Trump—yes, thank him—for opening

+ Read More